Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial

Robert K. Dyer, Martin A. Weinstock, Tobias S D Cohen, Amilcar E. Rizzo, Stephen F. Bingham, Martin A. Weinstock, Kimberly Marcolivio, Martin Wainstock, Stephen Binghem, John DiGiovanna, Russell Hall, Mark Naylor, J. Richard Taylor, Julia Vertrees, Clifton White, Russell Hell, Deborah Hannah, David Eilers, Tehming Liang, Nadia SaklaAnn Kreuger, Gary Cole, Edward Jeffes, Terri Labrador, J. Richard Taylor, Robert Kirsner, Jonette E. Kerri, Anna G. Falabella, Margarita Givens, Mark Neylor, Mary Beth Benson, Lisa Perry, James Kalivas, Catherine Yanni, Selma Targovnik, Janet Austin, Susan Collier, Joseph F. Collins, Stephen Bingam, Beverly Calvert, Philip Connor, Colleen Crigler, Dawn Davis, Pat Grubb, Judy Kelly, Gail Kirk, Karen Lawson, Linda Linzy, Lorrine Palmer, Maxine Rhoads, Mike Sather, Erica Copeland, Carol Fye, William Gagne, Patricia Grimes De Naranjo, Chad Messick, Julia Vertreas, Michael Piepkorn, Clifton Whita, Robert Lew, Irwin Braverman, Bernard Cole, Richard Kalish, David McLean, Bruce Thiers

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Basal cell carcinoma (BCC) is the most common cancer in the United States today, and patients who have had one are likely to have multiple carcinomas over time. Predictors of new BCCs on the face and ears among those at very high risk have not been studied in detail. We sought to do so prospectively in the context of a 6-year trial. We found that the number of BCCs in the prior 5 years was the most important predictor. Age, sun sensitivity, occupational sun exposure before the age of 30 years (but not afterward), lower educational level, history of eczema, the use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and more sunscreen use in the week, but not the 6 months, before enrollment were also independent predictors, but sunburns, baseline sun exposure, and other sun-protective measures, other skin cancers, and actinic keratoses were not. None of the eczema patients had a history of topical calcineurin use. The cumulative risk of BCC was 55% at 5 years. These findings document the key risk factors in this very high-risk population, suggesting that the history of eczema may increase the risk in those at high risk and that early sun exposure is important even in this group, and underscoring the need for chemopreventive strategies.

Original languageEnglish (US)
Pages (from-to)2544-2551
Number of pages8
JournalJournal of Investigative Dermatology
Volume132
Issue number11
DOIs
StatePublished - Nov 2012
Externally publishedYes

Fingerprint

Basal Cell Carcinoma
Chemoprevention
Solar System
Tretinoin
Sun
Cells
Eczema
Sunburn
Actinic Keratosis
Sunscreening Agents
Sun hoods
Calcineurin
Angiotensin Receptor Antagonists
Skin Neoplasms
Occupational Exposure
Angiotensin-Converting Enzyme Inhibitors
Ear
History
Skin
Carcinoma

ASJC Scopus subject areas

  • Dermatology
  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Dyer, R. K., Weinstock, M. A., Cohen, T. S. D., Rizzo, A. E., Bingham, S. F., Weinstock, M. A., ... Thiers, B. (2012). Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial. Journal of Investigative Dermatology, 132(11), 2544-2551. https://doi.org/10.1038/jid.2012.227

Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial. / Dyer, Robert K.; Weinstock, Martin A.; Cohen, Tobias S D; Rizzo, Amilcar E.; Bingham, Stephen F.; Weinstock, Martin A.; Marcolivio, Kimberly; Wainstock, Martin; Binghem, Stephen; DiGiovanna, John; Hall, Russell; Naylor, Mark; Taylor, J. Richard; Vertrees, Julia; White, Clifton; Hell, Russell; Hannah, Deborah; Eilers, David; Liang, Tehming; Sakla, Nadia; Kreuger, Ann; Cole, Gary; Jeffes, Edward; Labrador, Terri; Taylor, J. Richard; Kirsner, Robert; Kerri, Jonette E.; Falabella, Anna G.; Givens, Margarita; Neylor, Mark; Benson, Mary Beth; Perry, Lisa; Kalivas, James; Yanni, Catherine; Targovnik, Selma; Austin, Janet; Collier, Susan; Collins, Joseph F.; Bingam, Stephen; Calvert, Beverly; Connor, Philip; Crigler, Colleen; Davis, Dawn; Grubb, Pat; Kelly, Judy; Kirk, Gail; Lawson, Karen; Linzy, Linda; Palmer, Lorrine; Rhoads, Maxine; Sather, Mike; Copeland, Erica; Fye, Carol; Gagne, William; De Naranjo, Patricia Grimes; Messick, Chad; Vertreas, Julia; Piepkorn, Michael; Whita, Clifton; Lew, Robert; Braverman, Irwin; Cole, Bernard; Kalish, Richard; McLean, David; Thiers, Bruce.

In: Journal of Investigative Dermatology, Vol. 132, No. 11, 11.2012, p. 2544-2551.

Research output: Contribution to journalArticle

Dyer, RK, Weinstock, MA, Cohen, TSD, Rizzo, AE, Bingham, SF, Weinstock, MA, Marcolivio, K, Wainstock, M, Binghem, S, DiGiovanna, J, Hall, R, Naylor, M, Taylor, JR, Vertrees, J, White, C, Hell, R, Hannah, D, Eilers, D, Liang, T, Sakla, N, Kreuger, A, Cole, G, Jeffes, E, Labrador, T, Taylor, JR, Kirsner, R, Kerri, JE, Falabella, AG, Givens, M, Neylor, M, Benson, MB, Perry, L, Kalivas, J, Yanni, C, Targovnik, S, Austin, J, Collier, S, Collins, JF, Bingam, S, Calvert, B, Connor, P, Crigler, C, Davis, D, Grubb, P, Kelly, J, Kirk, G, Lawson, K, Linzy, L, Palmer, L, Rhoads, M, Sather, M, Copeland, E, Fye, C, Gagne, W, De Naranjo, PG, Messick, C, Vertreas, J, Piepkorn, M, Whita, C, Lew, R, Braverman, I, Cole, B, Kalish, R, McLean, D & Thiers, B 2012, 'Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial', Journal of Investigative Dermatology, vol. 132, no. 11, pp. 2544-2551. https://doi.org/10.1038/jid.2012.227
Dyer, Robert K. ; Weinstock, Martin A. ; Cohen, Tobias S D ; Rizzo, Amilcar E. ; Bingham, Stephen F. ; Weinstock, Martin A. ; Marcolivio, Kimberly ; Wainstock, Martin ; Binghem, Stephen ; DiGiovanna, John ; Hall, Russell ; Naylor, Mark ; Taylor, J. Richard ; Vertrees, Julia ; White, Clifton ; Hell, Russell ; Hannah, Deborah ; Eilers, David ; Liang, Tehming ; Sakla, Nadia ; Kreuger, Ann ; Cole, Gary ; Jeffes, Edward ; Labrador, Terri ; Taylor, J. Richard ; Kirsner, Robert ; Kerri, Jonette E. ; Falabella, Anna G. ; Givens, Margarita ; Neylor, Mark ; Benson, Mary Beth ; Perry, Lisa ; Kalivas, James ; Yanni, Catherine ; Targovnik, Selma ; Austin, Janet ; Collier, Susan ; Collins, Joseph F. ; Bingam, Stephen ; Calvert, Beverly ; Connor, Philip ; Crigler, Colleen ; Davis, Dawn ; Grubb, Pat ; Kelly, Judy ; Kirk, Gail ; Lawson, Karen ; Linzy, Linda ; Palmer, Lorrine ; Rhoads, Maxine ; Sather, Mike ; Copeland, Erica ; Fye, Carol ; Gagne, William ; De Naranjo, Patricia Grimes ; Messick, Chad ; Vertreas, Julia ; Piepkorn, Michael ; Whita, Clifton ; Lew, Robert ; Braverman, Irwin ; Cole, Bernard ; Kalish, Richard ; McLean, David ; Thiers, Bruce. / Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial. In: Journal of Investigative Dermatology. 2012 ; Vol. 132, No. 11. pp. 2544-2551.
@article{0f67255190484fc3bba6ee65e19ed6d8,
title = "Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial",
abstract = "Basal cell carcinoma (BCC) is the most common cancer in the United States today, and patients who have had one are likely to have multiple carcinomas over time. Predictors of new BCCs on the face and ears among those at very high risk have not been studied in detail. We sought to do so prospectively in the context of a 6-year trial. We found that the number of BCCs in the prior 5 years was the most important predictor. Age, sun sensitivity, occupational sun exposure before the age of 30 years (but not afterward), lower educational level, history of eczema, the use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and more sunscreen use in the week, but not the 6 months, before enrollment were also independent predictors, but sunburns, baseline sun exposure, and other sun-protective measures, other skin cancers, and actinic keratoses were not. None of the eczema patients had a history of topical calcineurin use. The cumulative risk of BCC was 55{\%} at 5 years. These findings document the key risk factors in this very high-risk population, suggesting that the history of eczema may increase the risk in those at high risk and that early sun exposure is important even in this group, and underscoring the need for chemopreventive strategies.",
author = "Dyer, {Robert K.} and Weinstock, {Martin A.} and Cohen, {Tobias S D} and Rizzo, {Amilcar E.} and Bingham, {Stephen F.} and Weinstock, {Martin A.} and Kimberly Marcolivio and Martin Wainstock and Stephen Binghem and John DiGiovanna and Russell Hall and Mark Naylor and Taylor, {J. Richard} and Julia Vertrees and Clifton White and Russell Hell and Deborah Hannah and David Eilers and Tehming Liang and Nadia Sakla and Ann Kreuger and Gary Cole and Edward Jeffes and Terri Labrador and Taylor, {J. Richard} and Robert Kirsner and Kerri, {Jonette E.} and Falabella, {Anna G.} and Margarita Givens and Mark Neylor and Benson, {Mary Beth} and Lisa Perry and James Kalivas and Catherine Yanni and Selma Targovnik and Janet Austin and Susan Collier and Collins, {Joseph F.} and Stephen Bingam and Beverly Calvert and Philip Connor and Colleen Crigler and Dawn Davis and Pat Grubb and Judy Kelly and Gail Kirk and Karen Lawson and Linda Linzy and Lorrine Palmer and Maxine Rhoads and Mike Sather and Erica Copeland and Carol Fye and William Gagne and {De Naranjo}, {Patricia Grimes} and Chad Messick and Julia Vertreas and Michael Piepkorn and Clifton Whita and Robert Lew and Irwin Braverman and Bernard Cole and Richard Kalish and David McLean and Bruce Thiers",
year = "2012",
month = "11",
doi = "10.1038/jid.2012.227",
language = "English (US)",
volume = "132",
pages = "2544--2551",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial

AU - Dyer, Robert K.

AU - Weinstock, Martin A.

AU - Cohen, Tobias S D

AU - Rizzo, Amilcar E.

AU - Bingham, Stephen F.

AU - Weinstock, Martin A.

AU - Marcolivio, Kimberly

AU - Wainstock, Martin

AU - Binghem, Stephen

AU - DiGiovanna, John

AU - Hall, Russell

AU - Naylor, Mark

AU - Taylor, J. Richard

AU - Vertrees, Julia

AU - White, Clifton

AU - Hell, Russell

AU - Hannah, Deborah

AU - Eilers, David

AU - Liang, Tehming

AU - Sakla, Nadia

AU - Kreuger, Ann

AU - Cole, Gary

AU - Jeffes, Edward

AU - Labrador, Terri

AU - Taylor, J. Richard

AU - Kirsner, Robert

AU - Kerri, Jonette E.

AU - Falabella, Anna G.

AU - Givens, Margarita

AU - Neylor, Mark

AU - Benson, Mary Beth

AU - Perry, Lisa

AU - Kalivas, James

AU - Yanni, Catherine

AU - Targovnik, Selma

AU - Austin, Janet

AU - Collier, Susan

AU - Collins, Joseph F.

AU - Bingam, Stephen

AU - Calvert, Beverly

AU - Connor, Philip

AU - Crigler, Colleen

AU - Davis, Dawn

AU - Grubb, Pat

AU - Kelly, Judy

AU - Kirk, Gail

AU - Lawson, Karen

AU - Linzy, Linda

AU - Palmer, Lorrine

AU - Rhoads, Maxine

AU - Sather, Mike

AU - Copeland, Erica

AU - Fye, Carol

AU - Gagne, William

AU - De Naranjo, Patricia Grimes

AU - Messick, Chad

AU - Vertreas, Julia

AU - Piepkorn, Michael

AU - Whita, Clifton

AU - Lew, Robert

AU - Braverman, Irwin

AU - Cole, Bernard

AU - Kalish, Richard

AU - McLean, David

AU - Thiers, Bruce

PY - 2012/11

Y1 - 2012/11

N2 - Basal cell carcinoma (BCC) is the most common cancer in the United States today, and patients who have had one are likely to have multiple carcinomas over time. Predictors of new BCCs on the face and ears among those at very high risk have not been studied in detail. We sought to do so prospectively in the context of a 6-year trial. We found that the number of BCCs in the prior 5 years was the most important predictor. Age, sun sensitivity, occupational sun exposure before the age of 30 years (but not afterward), lower educational level, history of eczema, the use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and more sunscreen use in the week, but not the 6 months, before enrollment were also independent predictors, but sunburns, baseline sun exposure, and other sun-protective measures, other skin cancers, and actinic keratoses were not. None of the eczema patients had a history of topical calcineurin use. The cumulative risk of BCC was 55% at 5 years. These findings document the key risk factors in this very high-risk population, suggesting that the history of eczema may increase the risk in those at high risk and that early sun exposure is important even in this group, and underscoring the need for chemopreventive strategies.

AB - Basal cell carcinoma (BCC) is the most common cancer in the United States today, and patients who have had one are likely to have multiple carcinomas over time. Predictors of new BCCs on the face and ears among those at very high risk have not been studied in detail. We sought to do so prospectively in the context of a 6-year trial. We found that the number of BCCs in the prior 5 years was the most important predictor. Age, sun sensitivity, occupational sun exposure before the age of 30 years (but not afterward), lower educational level, history of eczema, the use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and more sunscreen use in the week, but not the 6 months, before enrollment were also independent predictors, but sunburns, baseline sun exposure, and other sun-protective measures, other skin cancers, and actinic keratoses were not. None of the eczema patients had a history of topical calcineurin use. The cumulative risk of BCC was 55% at 5 years. These findings document the key risk factors in this very high-risk population, suggesting that the history of eczema may increase the risk in those at high risk and that early sun exposure is important even in this group, and underscoring the need for chemopreventive strategies.

UR - http://www.scopus.com/inward/record.url?scp=84867848114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867848114&partnerID=8YFLogxK

U2 - 10.1038/jid.2012.227

DO - 10.1038/jid.2012.227

M3 - Article

C2 - 22810303

AN - SCOPUS:84867848114

VL - 132

SP - 2544

EP - 2551

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 11

ER -